Loading...

FITC anti-human CD31 Antibody

Pricing & Availability
Clone
WM59 (See other available formats)
Regulatory Status
RUO
Workshop
V P025
Other Names
PECAM-1, EndoCAM
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
WM59_A_FITC_062207
  • WM59_A_FITC_062207
  • WM59_B_FITC_062207
    Human peripheral blood lymphocytes, monocytes and granulocytes were stained with CD31 (clone WM59) FITC (top) or mouse IgG1, κ FITC isotype control (bottom).
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
303103 25 tests $77
Check Availability


Need larger quantities of this item?
Request Bulk Quote
303104 100 tests $170
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD31 is a 130-140 kD type I transmembrane glycoprotein also known as platelet endothelial cell adhesion molecule-1 (PECAM-1) or Endocam. It is expressed on monocytes, platelets, granulocytes, endothelial cells and lymphocyte subsets. CD31 has been reported to bind CD38 and be involved in wound healing, angiogenesis, and cellular migration in an inflammatory situation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
African Green, Baboon
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone WM59 has been reported to recognize the D2 extracellular portion of CD31.

Additional reported applications (for the relevant formats) include: immunofluorescence microscopy2, immunohistochemical staining of acetone-fixed frozen tissue sections8, blocking of platelet aggregation3, and spatial biology (IBEX)11,12. Clone WM59 is not recommended for immunohistochemical staining of formalin-fixed paraffin-embedded sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 303143 & 303144).

The purified WM59 antibody is useful as a capture antibody for a sandwich ELISA assay, when used in conjunction with biotin anti-human CD31 antibody (Cat. No. 536604) antibody as the detection antibody.

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V Oxford University Press. New York.
  2. Muczynski KA, et al. 2003. J. Am. Soc. Nephrol. 14:1336. (IF)
  3. Wu XW, et al. 1997. Arterioscl. Throm. Vas. 17:3154. (Block)
  4. Nagano M, et al. 2007. Blood 110:151. (FC) PubMed
  5. MacFadyen JR, et al. 2005. FEBS Lett. 579:2569. PubMed
  6. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  7. Sestak K, et al. 2007. Vet. Immunol. Immunopathol. 119:21.
  8. Wicki A, et al. 2012. Clin. Cancer Res. 18:454. (FC, IHC) PubMed
  9. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. (FC) PubMed
  10. Bushway ME, et al. 2014. Biol Reprod. 90(5): 110 (IF) PubMed
  11. Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed
  12. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Abe I, et al. 2022. Dev Cell. 57:2623. PubMed
  2. Fu H, et al. 2023. Regen Ther. 22:7. PubMed
  3. Wei WJ, et al. 2022. Neural Regen Res. 17:2260. PubMed
  4. Gur C, et al. 2022. Cell. 185:1373. PubMed
  5. Vincent V, et al. 2020. Biotechniques. 68:325. PubMed
  6. Zhou Y, et al. 2020. Cancer Cell. 38(6):818-828.e5. PubMed
  7. Mulay A, et al. 2021. Cell Reports. 35(5):109055. PubMed
  8. Ferreira LB, et al. 2023. J Ophthalmic Inflamm Infect. 13:21. PubMed
  9. Aabling RR, et al. 2023. Regen Ther. 23:67. PubMed
  10. Lu Y, et al. 2023. Sci Rep. 13:8479. PubMed
  11. Qiu J, et al. 2020. Cell Rep. 33:108465. PubMed
  12. Liu X, et al. 2020. Exp Ther Med. 1.258333333. PubMed
  13. Nishino K, et al. 2021. Sci Rep. 11:8406. PubMed
  14. Marquez-Curtis LA, et al. 2022. PLoS One. 17:e0263005. PubMed
  15. Luzuriaga J, et al. 2019. Front Physiol. 10:347. PubMed
  16. MacFadyen JR, et al. 2005. FEBS Lett. 2005. PubMed
  17. Downes DJ, et al. 2021. Nat Genet. 53:1606. PubMed
  18. Dyring-Andersen B, et al. 2020. Nat Commun. 4.338194444. PubMed
  19. Wang D, et al. 2019. Cell Res. 29:832. PubMed
  20. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  21. Hamauchi S, et al. 2016. PLoS One. 11: 0163561. PubMed
  22. Koide M, et al. 2018. Tohoku J Exp Med. 244:15:00. PubMed
  23. Murakami T, et al. 2018. Nat Commun. 9:2436. PubMed
  24. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. PubMed
  25. Bieniasz–Krzywiec P, et al. 2020. Cell Metabolism. 30(5):917-936. PubMed
  26. Zhai X, et al. 2018. Oncol Lett. 15:1893. PubMed
  27. King D, et al. 2019. Sci Rep. 9:4157. PubMed
  28. Eikmans M, et al. 2022. Front Immunol. 13:814019. PubMed
  29. Vanoni G, et al. 2022. Bio Protoc. 218:. PubMed
  30. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  31. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  32. Nodomi S, et al. 2016. Oncogene. 10.1038/onc.2016.72. PubMed
  33. Kamali K, et al. 2021. Front Immunol. 12:647900. PubMed
  34. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  35. Sarveswaran K, et al. 2016. Sci Rep. 6:21885. PubMed
  36. Laird C, et al. 2017. Xenotransplantation. 10.1111/xen.12294. PubMed
  37. Li L, et al. 2020. Cell Res. . PubMed
  38. Liang H, et al. 2018. Oncogene. 15:1961. PubMed
  39. Escribano J, et al. 2019. PLoS Comput Biol. 15:e1006395. PubMed
  40. Luzuriaga J, et al. 2020. Biomedicines. 8:00. PubMed
  41. Yoon YJ, et al. 2022. Nat Commun. 13:3291. PubMed
  42. Wu SZ, et al. 2020. EMBO J. 39:e104063. PubMed
  43. Vanoni G, et al. 2021. eLife. 10:00. PubMed
  44. Hajal C, et al. 2022. Nat Protoc. 17:95. PubMed
  45. Chen G, et al. 2015. J Endod. 41: 1091-1099. PubMed
RRID
AB_314329 (BioLegend Cat. No. 303103)
AB_314329 (BioLegend Cat. No. 303104)

Antigen Details

Structure
Ig superfamily, type I transmembrane glycoprotein, 130-140 kD
Distribution

Monocytes, platelets, granulocytes, endothelial cells, lymphocyte subset

Function
Cell adhesion, signal transduction
Ligand/Receptor
CD38
Cell Type
Endothelial cells, Granulocytes, Lymphocytes, Monocytes, Neutrophils, Platelets
Biology Area
Angiogenesis, Cell Adhesion, Cell Biology, Immunology, Neuroinflammation, Neuroscience
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References
  1. DeLisser H, et al. 1994. Immunol. Today 15:490.
  2. Newman P, 1997. J. Clin. Invest. 99:3.
  3. Fawcett J, et al. 1995. J. Cell Biol. 128:1229.
Gene ID
5175 View all products for this Gene ID
UniProt
View information about CD31 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account